156
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Early Prediction Model of Gestational Hypertension by Multi-Biomarkers Before 20 Weeks Gestation

, , , , , ORCID Icon, & show all
Pages 2441-2451 | Published online: 31 May 2021

References

  • American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’Task Force on hypertension in pregnancy. Obstet Gynecol . 2013;122(5):1122–1131. doi:10.1097/01.AOG.0000437382.03963.88 24150027
  • Kuklina EV , Ayala C , Callaghan WM . Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol . 2009;113(6):1299–1306. doi:10.1097/AOG.0b013e3181a45b25 19461426
  • Riise HKR , Sulo G , Tell GS , et al. Association between gestational hypertension and risk of cardiovascular disease among 617589 Norwegian women. J Am Heart Assoc . 2018;7(10):e008337. doi:10.1161/JAHA.117.008337 29755034
  • Lomeli JMM , Castro NM . [Differences and similarities of preeclampsia and gestational hypertension]. Ginecol Obstet Mex . 2005;73(1):48–53. Spanish.15847148
  • Mannisto T , Mendola P , Vaarasmaki M , et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation . 2013;127(6):681–690. doi:10.1161/CIRCULATIONAHA.112.128751 23401113
  • Ying W , Catov JM , Ouyang P . Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc . 2018;7(17):e009382. doi:10.1161/JAHA.118.009382 30371154
  • Burton GJ , Jauniaux E . Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig . 2004;11(6):342–352. doi:10.1016/j.jsgi.2004.03.003
  • Knight M , Redman CW , Linton EA , et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol . 1998;105(6):632–640. doi:10.1111/j.1471-0528.1998.tb10178.x 9647154
  • Redman CW , Sargent IL . Placental debris, oxidative stress and preeclampsia. Placenta . 2000;21(7):597–602. doi:10.1053/plac.2000.0560 10985960
  • Conrad KP , Benyo DF . Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol . 1997;37(3):240–249. doi:10.1111/j.1600-0897.1997.tb00222.x 9127646
  • Zhou C , Long Y , Yang H , et al. TRAIL is decreased before 20 weeks gestation in women with hypertensive disorders of pregnancy. PLoS One . 2015;10(6):e0128425. doi:10.1371/journal.pone.0128425 26030414
  • Auer J , Camoin L , Guillonneau F , et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics . 2010;73(5):1004–1017. doi:10.1016/j.jprot.2009.12.014 20079470
  • Hensen A , Loeliger EA . Antithrombin iii. Its metabolism and its function in blood coagulation. Thromb Diath Haemorrh . 1963;83(SUPPL1):1–84.
  • Hu L , Ibrahim S , Liu C , et al. Induces tumor cell cycle activation and spontaneous growth by down-regulation of p27 Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res . 2009;69(8):3374–3381. doi:10.1158/0008-5472.CAN-08-4290 19351827
  • Hu L , Roth JM , Brooks P , et al. Twist is required for thrombin-induced tumor angiogenesis and growth. Cancer Res . 2008;68(11):4296–4302. doi:10.1158/0008-5472.CAN-08-0067 18519689
  • Hu L , Roth JM , Brooks P , et al. Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res . 2008;68(12):4666–4673. doi:10.1158/0008-5472.CAN-07-6276 18559512
  • Larsson H , Sjöblom T , Dixelius J , et al. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res . 2000;60(23):6723–6729.11118058
  • Sil H , Sen T , Chatterjee A . Fibronectin‐integrin (α5β1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9. Oncol Res . 2011;19(7):335–348. doi:10.3727/096504011x13079697132925 21936403
  • Asanuma K , Yoshikawa T , Hayashi T , et al. Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity. Int J Cancer . 2007;121(5):955–965. doi:10.1002/ijc.22773 17450526
  • Lash GE , Otun HA , Innes BA , et al. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system. Biol Reprod . 2006;74(2):403–409. doi:10.1095/biolreprod.105.047332 16251495
  • Kim SM , Cho BK , Kang MJ , et al. Expression changes of proteins associated with the development of preeclampsia in maternal plasma: a case-control study. Proteomics . 2016;16(10):1581–1589. doi:10.1002/pmic.201500381 27001287
  • Kolla V , Jenö P , Moes S , et al. Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol . 2012;2012:305964. doi:10.1155/2012/305964 22570525
  • Alrahmani L , Willrich MAV . The complement alternative pathway and preeclampsia. Curr Hypertens Rep . 2018;20(5):40. doi:10.1007/s11906-018-0836-4 29717384
  • Csincsi ÁI , Kopp A , Zöldi M , et al. Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation. J Immunol . 2015;194(10):4963–4973. doi:10.4049/jimmunol.1403121 25855355
  • Brocklebank V , Wood KM , Kavanagh D . Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol . 2018;13(2):300–317. doi:10.2215/CJN.00620117 29042465
  • Zhu L , Guo WY , Shi SF , et al. Circulating complement factor H related protein 5 levels contribute to development and progression of IgA nephropathy. Kidney Int . 2018;94(1):150–158. doi:10.1016/j.kint.2018.02.023 29759419
  • Chen Q , Manzke M , Hartmann A , et al. Complement factor H-related 5-hybrid proteins anchor properdin and activate complement at self-surfaces. J Am Soc Nephrol . 2016;27(5):1413–1425. doi:10.1681/ASN.2015020212 26432903
  • Jones SE , Jomary C . Clusterin. Int J Biochem Cell Biol . 2002;34(5):427–431. doi:10.1016/s1357-2725(01)00155-8 11906815
  • Watanabe H , Hamada H , Yamada N , et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics . 2004;4(2):537–543. doi:10.1002/pmic.200300565 14760726
  • Shin JK , Han KA , Kang MY , et al. Expression of clusterin in normal and preeclamptic placentas. J Obstet Gynaecol Res . 2008;34(4):473–479. doi:10.1111/j.1447-0756.2008.00723.x 18946934
  • Hsu TH , Hsieh TT , Yang KD , et al. Proteomic profiling reveals a1-antitrypsin, a1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women. Taiwan J Obstet Gynecol . 2015;54(5):499–504. doi:10.1016/j.tjog.2014.01.007 26522099
  • Witte DP , Aronow BJ , Stauderman ML , et al. Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol . 1993;143(3):763–773.8362975
  • Huppertz B , Kingdom J , Caniggia I , et al. Hypoxia favours necrotic versus apoptotic shedding of placental 298 syncytiotrophoblast into the maternal circulation. Placenta . 2003;24(2–3):181–190. doi:10.1053/plac.2002.0903 12566245
  • Correa RR , Gilio DB , Cavellani CL , et al. Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet . 2008;277(3):201–206. doi:10.1007/s00404-007-0452-z 17786461
  • Hefler LA , Tempfer CB , Bancher-Todesca D , et al. Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia. J Soc Gynecol Investig . 2001;8(3):169–173. doi:10.1016/S1071-5576(01)00108-3
  • Bancher-Todesca D , Hefler L , Zeisler H , et al. Placental expression of cytokeratin 18 and serum levels of tissue polypeptide antigen in women with pregnancy-induced hypertension. Hypertens Pregnancy . 2001;20(1):89–98. doi:10.1081/PRG-100104175 12044317
  • Li XL , Dong X , Xue Y , et al. Increased expression levels of E-cadherin, cytokeratin 18 and 19 observed in preeclampsia were not correlated with disease severity. Placenta . 2014;35(8):625–631. doi:10.1016/j.placenta.2014.04.010 24857367
  • Nordqvist S , Karehed K , Skoog Svanberg A , et al. Ovarian response is affected by a specific histidine-rich glycoprotein polymorphism: a preliminary study. Reprod Biomed Online . 2015;30(1):74–81. doi:10.1016/j.rbmo.2014.09.016 25456162
  • Poon IK , Patel KK , Davis DS , et al. Histidinerich glycoprotein: the Swiss Army knife of mammalian plasma. Blood . 2011;117(7):2093–2101. doi:10.1182/blood-2010-09-303842 20971949
  • Bolin M , Akerud P , Hansson A , et al. Histidine-rich glycoprotein as an early biomarker of preeclampsia. Am J Hypertens . 2011;24(4):496–501. doi:10.1038/ajh.2010.264 21252863
  • Bolin M , Wikstrom AK , Wiberg-Itzel E , et al. Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery Doppler. Am J Hypertens . 2012;25(12):1305–1310. doi:10.1038/ajh.2012.112 22895448
  • Karehed K , Wikstrom AK , Olsson AK , et al. Fibrinogen and histidine-rich glycoprotein in early onset preeclampsia. Acta Obstet Gynecol Scand . 2010;89(1):131–139. doi:10.3109/00016340903295618 19878090
  • Jones AL , Hulett MD , Parish CR . Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol . 2005;83(2):106–118. doi:10.1111/j.1440-1711.2005.01320.x 15748207
  • Johnson LD , Goubran HA , Kotb RR . Histidine rich glycoprotein and cancer: a multi-faceted relationship. Anticancer Res . 2014;34(2):593–603.24510988
  • Brown MB , von Chamier M , Allam AB , et al. M1/M2 macrophage polarity in normal and complicated pregnancy. Front Immunol . 2014;5:606. doi:10.3389/fimmu.2014.00606 25505471
  • Dixelius J , Olsson AK , Thulin A , et al. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Cancer Res . 2006;66(4):2089–2097. doi:10.1158/0008-5472.CAN-05-2217 16489009
  • Lee C , Dixelius J , Thulin A , et al. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res . 2006;312(13):2547–2556. doi:10.1016/j.yexcr.2006.04.022 16769050
  • Shokry M , Bedaiwy MA , Fathalla MM , et al. Maternal serum placental growth factor and soluble fms‐like tyrosine kinase 1 as early predictors of preeclampsia. Acta Obstet Gynecol Scand . 2010;89(1):143–146. doi:10.3109/00016340903289892 20021269
  • Rayman MP , Barlis J , Evans RW , et al. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol . 2002;187(2):412–418. doi:10.1067/mob.2002.123895 12193935